Market revenue in 2023 | USD 6.8 million |
Market revenue in 2030 | USD 24.4 million |
Growth rate | 20% (CAGR from 2023 to 2030) |
Largest segment | Pre-clinical |
Fastest growing segment | Pre-clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pre-clinical, Clinical |
Key market players worldwide | Lonza Group Ltd, Catalent Inc, Cytiva, Samsung Electronics Co Ltd, Thermo Fisher Scientific Inc, Novartis AG ADR, Wuxi AppTec Co Ltd, AGC Inc, OmniAb Inc, Rentschler Biopharma SE, Charles River Laboratories International Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy cdmo market will help companies and investors design strategic landscapes.
Pre-clinical was the largest segment with a revenue share of 66.18% in 2023. Horizon Databook has segmented the Kuwait cell and gene therapy cdmo market based on pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The cell and gene therapy CDMO market in Kuwait is expected to grow considerably due to the increasing number of CDMOs, rising demand for advanced drug therapeutics, access to high-value products, capacity to produce innovative drugs locally, and favorable regulatory controls.
Moreover, the growing adoption of gene therapeutics is expected to create opportunities for cell & gene therapy CDMOs in Kuwait. In addition, the establishment and expansion of products in the country is another major factor fueling market growth.
Hence, the increasing number of research activities, pharmaceutical companies, and government support for drug development are expected to contribute to market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait cell and gene therapy cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait cell and gene therapy cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account